Work

Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival

Year: 2009

Type: article

Study design: Clinical Trial

Source: International Journal of Cancer

DOI: 10.1002/ijc.24850

Authors: Julia Karbach, Sacha Gnjatic, Armin Bender, Antje Neumann, Eckhart Weidmann, Jianda Yuan, Cathy A. Ferrara, Eric Hoffmann, Lloyd J. Old, Nasser K. Altorki, Elke Jäger

Institutions: Krankenhaus Nordwest, Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research, Universitätsklinikum Gießen und Marburg, NewYork–Presbyterian Hospital, Cornell University, Weill Cornell Medicine

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1964163749

FWCI: 4.205

Cites: 47

Cited by: 113

Related to: 10